Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
The therapeutic promise of induced pluripotent stem cells (iPSCs) has spurred efforts to circumvent genome alteration when reprogramming somatic cells to pluripotency. Approaches based on episomal DNA, Sendai virus, and messenger RNA (mRNA) can generate "footprint-free" iPSCs with efficiencies equaling or surpassing those attained with integrating viral vectors. The mRNA method uniquely affords unprecedented control over reprogramming factor (RF) expression while obviating a cleanup phase to purge residual traces of vector. Currently, mRNA-based reprogramming is relatively laborious due to the need to transfect daily for ~2 weeks to induce pluripotency, and requires the use of feeder cells that add complexity and variability to the procedure while introducing a route for contamination with non-human-derived biological material. We accelerated the mRNA reprogramming process through stepwise optimization of the RF cocktail and leveraged these kinetic gains to establish a feeder-free, xeno-free protocol which slashes the time, cost and effort involved in iPSC derivation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In other words, it cannot be applied successfully to cells that are inherently grown in suspension (such as blood cells) due to the negative impact of multiple rounds of transfections on cell viability.”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [37]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“mRNA reprogramming is usually applied only to cells that can survive multiple rounds of transfections, such as adherent cells (i.e., fibroblasts).”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Culture of Animal Cells: A Manual of Basic Technique and Specialized Applications
Freshney, R. I. (2010) · Wiley eBooks · doi:10.1002/9780470649367 · Cited by 3,870
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662
Self-citationHuman induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors
Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1164270 · Cited by 2,009
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., et al. (2009) · Nature · doi:10.1038/nature07863 · Cited by 1,814
Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins
Zhou, H., Wu, S., Joo, J. Y., Zhu, S., Han, D. W., Lin, T., Trauger, S., Bien, G., Yao, S., Zhu, Y., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.04.005 · Cited by 1,788
FUSAKI, N., BAN, H., NISHIYAMA, A., SAEKI, K., & HASEGAWA, M. (2009) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.85.348 · Cited by 1,411
Cited by
Items 101–154 of 154
Lam, I., Ndayisaba, A., Lewis, A. J., Fu, Y., Sagredo, G. T., Zaccagnini, L., Sandoe, J., Sanz, R. L., Vahdatshoar, A., Martin, T. D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.08.515615 · Cited by 8
Supramolecular Gene Transfection Agents
Pitard, B., & Habrant, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12563-6 · Cited by 9
Lee, K.-I., Lee, S., & Hwang, D. (2016) · Stem Cells International · doi:10.1155/2016/6853081 · Cited by 7
“To performmRNA-mediated reprogramming, the initial and subsequent studies used human feeder cells, and human neonatal fibroblast- (NuFF-) conditioned medium [11, 12, 15, 16].”
Chemical Reprogramming of Somatic Cells in Neural Direction: Myth or Reality?
Samoilova, E. M., Revkova, V. A., Brovkina, O., Анатольевич, К. В., Melnikov, P., Анатольевич, К. М., Galimov, K. R., Nikitin, A. G., Troitskiy, A. V., & Baklaushev, V. P. (2019) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-019-04570-5 · Cited by 7
Cappella, M., Elouej, S., & Biferi, M. G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.662837 · Cited by 9
Minnaert, A., Devoldere, J., Peynshaert, K., Vercruysse, L., Smedt, S. C. D., & Remaut, K. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010074 · Cited by 6
Expanding horizons of cellular plasticity in regenerative medicine.
Sen, C. (2015) · American Journal of Pathology · doi:10.1016/j.ajpath.2015.06.003 · Cited by 6
“mRNA-based reprogramming represents another option for virus-free transduction.(37) However, limitations of such approach include inherent complexities related to cellular procedures and purification of reprogrammed cells.”
BackgroundInfluentialSfougataki, I., Grafakos, I., Varela, I., Mitrakos, A. K., Karagiannidou, A., Tzanoudaki, M., Poulou, M., Mertzanian, A., Roubelakis, M. G., Stefanaki, K., et al. (2019) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2019.01.003 · Cited by 6
Dey, C., Raina, K., Thool, M., Adhikari, P., Haridhasapavalan, K. K., Sundaravadivelu, P. K., Venkatesan, V., Gogoi, R., Selvaraju, S., & Thummer, R. P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90059-1.00007-5 · Cited by 8
Konteles, V., Papathanasiou, I. V., Tzetis, M., Goussetis, E., Trachana, V., Mourmoura, E., Balis, C., Malizos, Κ. Ν., & Tsezou, A. (2023) · Cells · doi:10.3390/cells12131756 · Cited by 6
Design and Production of mRNA-based Gene Vectors for Therapeutic Reprogramming of Cell Fate
Tolmachov, O. E. (2014) · Gene Technology · doi:10.4172/2329-6682.1000117 · Cited by 6
Fabricating the cartilage: recent achievements
Fani, N., Peshkova, M., Bikmulina, P. Y., Golroo, R., Timashev, P. S., & Vosough, M. (2023) · Cytotechnology · doi:10.1007/s10616-023-00582-2 · Cited by 5
Role of Nanotechnology in Epigenetic Reprogramming
Kadengodlu, P. A., & Ravishankar, V. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0309 · Cited by 7
“This reduced the time to half of what was needed using the traditional approaches [82].”
InfluentialCell therapies for treatment of human immunodeficiency virus infection
Focosi, D., Maggi, F., Ceccherini‐Nelli, L., & Pistello, M. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1831 · Cited by 4
Stem Cells: Are We Ready for Therapy?
Schroeder, I. S. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1453-1_1 · Cited by 4
Chemical transdifferentiation of somatic cells to neural cells: a systematic review
Visintin, P. V., Zampieri, B. L., & Griesi‐Oliveira, K. (2024) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2024rw0423 · Cited by 3
“…this issue, transdifferentiation can also be induced by exogenous TFs delivered to the cells using integration-free viruses, (16) plasmid DNA (17) (which have a reduced, but not null, risk of insertion into the genome), synthetic mRNA, (18) epigenetic modifiers, (19) or recombinant proteins.”
Miliotou, Α. N., Pappas, I. S., Vizirianakis, I. S., & Papadopoulou, L. C. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_10 · Cited by 3
Direct reprogramming of somatic cells: an update
Pham, P. V. (2015) · Biomedical Research and Therapy · doi:10.7603/s40730-015-0008-y · Cited by 4
“To date, the safest technique of iPSC production is induction of pluripotency via mRNA (Warren et al., 2012; Yoshioka et al., 2013) or protein (Kim et al., 2009; Lee et al., 2012).”
hiPSCs: Reprogramming towards cell-based therapies
Woolwine, P. E. (2013) · Open Journal of Regenerative Medicine · doi:10.4236/ojrm.2013.23010 · Cited by 3
Tsou, H., Chang, C.-C., Maeda, T., & Lin, C. (2022) · RNA technologies · doi:10.1007/978-3-031-08415-7_18 · Cited by 3
Khandani, B., & Movahedin, M. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10662-7 · Cited by 2
Thai, H. B. D., Jung, W., Choi, S., Kim, W. J., Moon, J., & Lim, B. C. (2025) · Korean Journal of Pediatrics · doi:10.3345/cep.2024.01830 · Cited by 3
“21) Of note, the deletions detected on chromosomes 8, 9, and 19, which are just partially explored, are concerning because they impact the stability and differentiation capacity of these cells.”
Induced Pluripotent Stem Cell-Derived Autologous Cell Therapy for Age-Related Macular Degeneration
Khristov, V., Jha, B. S., Rising, A. C., Li, Y., Qian, H., Maminishkis, A., Amaral, J., Campos, M. M., & Bharti, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-49479-1_3 · Cited by 3
Industry Update: Latest developments in Stem Cell Research and Regenerative Medicine
Ilić, D. (2012) · Regenerative Medicine · doi:10.2217/rme.12.107 · Cited by 2
CRISPR/Cas9 Editing in Induced Pluripotent Stem Cells: A Way Forward for Treating Cystic Fibrosis?
Quiroz, E. J., & Ryan, A. L. (2019) · Springer eBooks · doi:10.1007/978-3-030-29403-8_9 · Cited by 3
Stem Cells of the Human Corneoscleral Niche
McLenachan, S., Zhang, D., & Chen, F. K. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4939-0787-8_11 · Cited by 1
“Since 2006, a variety of methods for inducing transcription factor expression in adult primary cultures have been developed that may be suitable for clinical implementation, including transfection of episomal plasmids, mRNA, micro-RNA, and the delivery of recombinant proteins [ 83 – 87 ].”
BackgroundDerivation of Induced Pluripotent Stem Cells
Healy, L. E., & Ruban, L. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7507-2_9 · Cited by 1
In Vitro Methods for Generating Induced Pluripotent Stem Cells
Ahmed, T. A., Elshenawy, S. E., Essawy, M., Mohamed, R. H., & El‐Badri, N. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-55359-3_9 · Cited by 1
Cell Therapy for Blood Substitutes
Lu, S., & Lanza, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809880-6.00052-7 · Cited by 1
An Introduction to Cellular Reprogramming: The Plasticity of Cell Fates and Identities
Smith, K. P., Borowski, M., & Laning, J. C. (2014) · Wiley eBooks · doi:10.1002/9781118695746.ch8 · Cited by 1
The Synthetic Biology Approach to Stem Cells and Regenerative Medicine
Heng, B. C., & Fussenegger, M. (2014) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.20120067 · Cited by 1
Jarazo, J. (2014) · Louisiana State University · doi:10.31390/gradschool_theses.2646 · Cited by 1
“Our approach to develop an induction of pluripotency treatment without the use of feeder-layers resides in the need to reduce any possible immunogenic agent that might be altering the cells used in regenerative therapy (Warren et al., 2012).”
BackgroundiPSC-Derived MSCs that Are Genetically Engineered for Systemic Bone Augmentation
Zhang, X. (2012) · Defense Technical Information Center (DTIC) · doi:10.21236/ada568164
Mongre, R. K., Sodhi, S. S., Ghosh, M., Kim, J. H., Kim, N., Sharma, N., Oh, S. J., Kim, S. W., & Jeong, D. K. (2014) · Journal of animal research · doi:10.5958/2277-940x.2014.00081.3
“MARKERS OF PLURIPOTENCY AND THEIR APPLICATIONS Ectopic expression of the transcription factors Oct4, Sox2, c-Myc, and Klf4 in fibroblasts generates iPSCs (Takahashi and Yamanaka, 2006; Yu et al., 2007; Park et al., 2008; Yu et al., 2009; Okita et al., 2010; Stadtfeld and Hochedlinger, 2010; Warren et al., 2012).”
BackgroundHealing Cartilage -Aspects on Regenerative Methods
Enochson, L. (2013) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Induced Pluripotent Stem-cell Lines in the Clinic - Still a Long Road Ahead
Bhatt, S. (2015) · Journal of Human Virology & Retrovirology · doi:10.15406/jhvrv.2015.02.00044
INDUCED PLURIPOTENT STEM CELLS: WHERE ARE WE TODAY?
Dénommé, G. M. (2015) · Lu Zone Ul (Laurentian University)
Non-human primate iPS cells for cell replacement therapies and human cardiovascular disease modeling
Rodríguez-Polo, I. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7757
High-throughput Human Cell Reprogramming through Substrate and Microfluidics Integration
Giulitti, S. (2014) · Padua@research (University of Padova)
Induced pluripotent stem cells for cystic fibrosis
Laselva, O., & Conese, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99892-5.00014-1
Weiner, J. A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734891244.793556605
Induced pluripotent stem cells for cardiovascular therapeutics: Progress and perspectives
Kizub, I. V. (2023) · Regulatory Mechanisms in Biosystems · doi:10.15421/10.15421/022366
Injury and Repair: Stem Cells and Retinal Transplantation
Tucker, B. A., & Young, M. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13820-1.00073-6
Generation of Donor-Specific iPSC for Modelling Lysosomal Storage Disorders
Chear, S., Chiam, A., Talbot, J., Thorne, B. N., Wilkinson, E. J., Hewitt, A. W., & Cook, A. L. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4844-5_12
Clonidine prevents radiation-induced cell death in human brain organoids
Lundberg, M., Samudyata, S., Koskuvi, M., Gkogka, A., Nikpour, M., Çelik, M., Smedler, E., Stenerlöw, B., Lönnqvist, P., Schalling, M., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-26170-2 · Cited by 3
Li, M., Deng, H., Xu, H., Zhou, Q., & Zhao, S. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1842955
“An inducible suicide gene (e.g., iCasp9) provides an additional safety switch (Steinle et al., 2016; Warren et al., 2012).”
Haberhausen, D., Woehle, C., Raab, C., Ludwig, C., Kuchler, T., Barth, S., Wuellner, U., Bosio, A., Johannsen, H., & Knöbel, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.04.741960
“Although successfully established mRNA-based approaches work for long-lived fibroblast cell lines like BJ cells (14), reprogramming success rates are often inconsistent when applied to freshly isolated donor cells (6).”
Induced Pluripotent Stem Cells in Non-Model Species: Applications and Challenges
Bao, Q., Tay, N. L., Lim, C. Y., Xie, S., Ng, S. C., & Pomp, O. (2026) · Cells · doi:10.3390/cells15171565
“…the principal limitations of conventional synthetic mRNA delivery: the requirement for high input doses to achieve sustained transgene expression [75]. saRNA constructs encode both the reprogramming factors and a viral RNA-dependent RNA polymerase (typically derived from alphaviruses such as…”
From Primary Cells to Organoids: Expanding the Biological Relevance of In Vitro Cellular Models
Deng, F., Wang, Y., Castellano, L. A., & Zhao, C. (2026) · Cells · doi:10.3390/cells15191741
“Delivery of modified mRNAs encoding reprogramming factors can generate iPSCs without genomic integration while achieving relatively high efficiency and rapid kinetics [134].”
Metadata
- Authors
- Warren, L., Ni, Y., Wang, J., & Guo, X.
- Affiliations
- Allele Biotechnology (United States) (US)
- Nanjing Maternity and Child Health Care Hospital (CN)
- Scintillon Institute (US)
- Corresponding author
- Wang, Jiwu
- Guo, Xirong
- Venue
- Scientific Reports
- Published
- 2012-09-14
- Volume
- 2
- Issue
- 1
- Pages
- 657-657
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3442198
- OpenAlex
- W2003316226
- Cited by
- 154
- References
- 46
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 6 · 2023: 8 · 2022: 7 · 2021: 9 · 2020: 4 · 2019: 13 · 2018: 18 · 2017: 4 · 2016: 10 · 2015: 20 · 2014: 31 · 2013: 14 · 2012: 3
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81100618, 30973231)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, feeder-free culture, somatic cell reprogramming
- MeSH terms
- Nanog Homeobox Protein, Cell Survival, Cells, Cultured, Humans, RNA, Messenger, Herpes Simplex Virus Protein Vmw65, MyoD Protein, Homeodomain Proteins, Coculture Techniques, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.